Donor Selection and Allocation
Donor selection and allocation is the area of transplantation surgery concerned with how organs are sourced, who may donate, how donor and recipient suitability is assessed, and by what rules a scarce organ is matched to a candidate on the waiting list. It spans living and deceased donation, immunologic compatibility testing, and the policy systems that distribute organs equitably and efficiently.
Definition
Donor selection and allocation refers to the assessment of potential organ donors (living or deceased), the determination of donor-recipient compatibility, and the application of allocation policy to distribute organs among waiting candidates.
Scope
The area covers the evaluation and surgery of living donors, the management of deceased donors after brain death or circulatory death, histocompatibility testing and crossmatching, and the allocation algorithms and waitlist management that govern organ distribution. It is framed as a reference overview of how the donation-to-transplant pathway is organized, not as operative or clinical instruction.
Sub-topics
Core questions
- Who can safely and ethically donate an organ, and how is suitability assessed?
- How are deceased donors identified, certified, and physiologically maintained until procurement?
- How is immunologic compatibility between donor and recipient established?
- By what principles are scarce organs allocated among waiting candidates?
Key concepts
- Living versus deceased donation
- Donation after brain death and after circulatory death
- Histocompatibility and crossmatching
- Donor risk indices
- Organ allocation policy
- Waitlist mortality and equity
- Organ shortage
Mechanisms
Organs reach recipients along two donation pathways: living donation, in which a healthy person undergoes evaluation and surgery to donate a kidney or partial organ, and deceased donation, in which organs are recovered after death is certified by neurologic or circulatory criteria. Candidate-donor compatibility is established through blood-group and human leukocyte antigen typing and crossmatching, and the resulting organ is matched to a waitlist candidate through allocation algorithms that weigh urgency, expected benefit, waiting time, and equity. Because demand persistently exceeds supply, donor quality scoring, expanded donor criteria, and organ preservation strategies are used to broaden the usable donor pool while protecting outcomes.
Clinical relevance
The structures described here determine which patients can be transplanted and when, and they underlie the survival advantage that transplantation confers over remaining on the waiting list. The entry summarizes how donation and allocation systems are organized for educational reference and does not provide operative technique or individualized clinical direction.
Epidemiology
Across solid-organ programs, the number of candidates on transplant waiting lists greatly exceeds the number of available organs, and a measurable fraction of candidates die or are removed from lists while waiting. Efforts to close this gap include living donation, donation after circulatory death, and the use of higher-risk or expanded-criteria donors, each of which changes the composition of the donor pool.
Evidence & guidelines
Living donor evaluation is guided by the KDIGO living kidney donor guideline (Lentine and colleagues, 2017), deceased-donor terminology for circulatory-death donation by the modified Maastricht classification (Thuong and colleagues, 2016), and the rationale for transplantation over dialysis by landmark survival comparisons (Wolfe and colleagues, 1999). These sources frame donation and allocation as evolving, evidence- and policy-driven systems.
History
Solid-organ transplantation moved from experimental to therapeutic over the second half of the twentieth century, beginning with Joseph Murray's living-donor kidney transplant between identical twins in 1954 and advancing through Thomas Starzl's work in liver transplantation and immunosuppression. The acceptance of neurologic criteria for death in the late 1960s enabled organized deceased donation, and the persistent shortage of organs subsequently drove the development of formal allocation systems, donor scoring, and circulatory-death donation.
Key figures
- Thomas Starzl
- Joseph Murray
- Robert Wolfe
Related topics
Seminal works
- wolfe-1999
- lentine-2017
- thuong-2016
Frequently asked questions
- What is the difference between living and deceased donation?
- In living donation a healthy person donates a kidney or part of an organ such as the liver, whereas in deceased donation organs are recovered after death has been certified by neurologic (brain death) or circulatory criteria.
- Why is organ allocation necessary?
- Because the number of patients needing a transplant far exceeds the number of available organs, allocation systems apply explicit rules to distribute scarce organs in a way that balances medical urgency, expected benefit, and fairness.